Benzinga | Aug 17, 2020 07:25AM EDT

HC Wainwright & Co. Maintains Buy on Leap Therapeutics, Lowers Price Target to $4

HC Wainwright & Co. maintains Leap Therapeutics (NASDAQ:LPTX) with a Buy and lowers the price target from $5 to $4.